Yingnan Zhao, PhD

Assistant Professor of Pharmacy Administration

Division of Clinical and Administrative Sciences

Yingnan Zhao is an assistant professor of pharmacy administration at Division of Clinical and Administrative Sciences. Dr. Zhao holds a master of sciences degree in Medicinal Administration from University of Macau; and a PhD degree in Health Systems Management from Tulane University. She has participated in a variety of projects in health economic evaluation and outcomes research, with an extensive experience in secondary database analysis. She joined XULA in 2013 after serving in a new pharmacy program for two years, where she built three courses and implemented team-based learning in daily teaching. 

Education:

• PhD in Health Systems Management, Tulane University, New Orleans, Louisiana
• MS in Medicinal Administration, University of Macau, Macau
• BS in Biological Sciences, Fudan University, Shanghai, China

Clinical Specialties: (as applies)

N/A

Teaching Areas: (as applies)

• PHAD 5320 Pharmacy Management
• PHAD 5220 Pharmacoeconomics and Health Outcomes
• PHAD 5500 China Health Care System
• PHAD 4430 Practice Management and Pharmacoeconomics
• PHAD 4410 Pharmacy Management
• PHCY 821/721 Pharmacoeconomics
• PHCY 722 Biostatistics and Literature Evaluation

Research Interests: (as applies)

Dr. Zhao's current research interests include establishing the essential need for new medications and evaluating new medications comparatively in real-world applications and health care equity in access, quality, and outcome. She is also interested in pharmacoepidemiology with the focus on safety issues in medication treatment and medical informatics to improve quality of patient care. The majority of her research has been conducted in the area of chronic disease (e.g., diabetes and hypertension) and quality of care for health systems.

Select Publications: (as applies)

• Yingnan Zhao, Qian Shi, Yao Wang, Vivian Fonseca, Lizheng Shi. Economic burden of hypoglycemia: Utilization of emergency department and outpatient services in the United States (2005-2009). J Med Econ. 2016 Sep;19(9):852-7.
• Qian Shi, Vivian Fonseca, Marie Krousel-Wood, Yingnan Zhao, Frank P. Nellans, Qingyang Luo, Lizheng Shi. Will the Affordable Care Act Improve Racial Disparity of Eye Examination Among US Working-Age Population with Diabetes? Curr Diab Rep. 2016 Jul;16(7):58.
• Yingnan Zhao, Sumesh Kachroo, Hugh Kawabata, Susan Colilla, Jayanti Mukherjee, Vivian Fonseca, Uchenna Iloeje, Lizheng Shi. Association between Hypoglycemia and Fall-Related Fractures and Health Care Utilization in Older Veterans with Type 2 Diabetes. Endocrine Practice. 2016 Feb;22(2):196-204.
• Liya Wang, Monika Sawhney, Yingnan Zhao, Gandahari Rosa Carpio, Vivian Fonseca, Lizheng Shi. The Association between Colchicine and Risk of Diabetes among Veterans Affairs Population with Gout. Clinical Therapeutics. 2015 Jun 1;37(6):1206-15.
• Lizheng Shi, Hui Shao, Yingnan Zhao, Nina A Thomas. Is Hypoglycemia Fear Independently Associated with Health-Related Quality of Life? Health Qual Life Outcomes. 2014;12(1):167.
• Qian Shi, Yingnan Zhao, Vivian Fonseca, Marie Krousel-Wood, Lizheng Shi. Racial Disparity of Eye Examinations Among the U.S. Working-Age Population with Diabetes: 2002-2009. Diabetes Care. 2014 May; 37(5):1321-1328.
• Rajesh Vadlapatla, Sukhvir Kaur, Yingnan Zhao. Evaluation of Student Perceptions of Concept Mapping Activity in a Didactic Pharmaceutics Course. Currents in Pharmacy Teaching and Learning. 2014 Jul-Aug; 6(6):543-549.
• Lizheng Shi, Tina Thethi, Yingnan Zhao. Diabetes Risk Assessment Models: We Have the Base, But Not Enough? Journal of Diabetes and Its Complications. 2013 Jul-Aug;27(4):305-6.
• Yingnan Zhao, Claudia Campbell, Vivian Fonseca, Lizheng Shi. Impact of Hypoglycemia Associated with Anti-hyperglycemic Medications on Vascular Risks in Veterans with Type 2 Diabetes Mellitus. Diabetes Care. 2012 May; 35(5):1126-32.
• Shuqian Liu, Yingnan Zhao, James Hempe, Vivian Fonseca, Lizheng Shi. Economic burden of hypoglycemia in patients with type 2 diabetes. Expert Review of Pharmacoeconomics & Outcomes Research. 2012 Feb; 12(1):47-51.
• Yingnan Zhao, Jinan Liu, Yang Zhao, Tina Thethi, Vivian Fonseca, Lizheng Shi. Predictors of Duloxetine versus Other Treatments among Veterans with Diabetic Peripheral Neuropathic Pain (DPNP): A Retrospective Study. Pain Practice. 2012 Jun;12(5):366-73.
• Lizheng Shi, Yingnan Zhao, Candy Yau, Keith Szymanski, Vivian Fonseca. Impact of Thiazolidinedione (TZD) Safety Warnings on Medication Use Patterns and Glycemic Control Among Veterans with Diabetes Mellitus. J Diabetes Complications. 2011; 25:143-150.
• Lizheng Shi, Yingnan Zhao, Vivian Fonseca, Haya Ascher-Svanum, Yi-Ju Chiang, Daniel Winstead. Healthcare Resource Utilization, Adherence and Persistence with Antipsychotic Therapy among Schizophrenia Patients with vs. without Pre-Existing Metabolic Syndrome. Curr Med Res Opin. 2010 Oct;26(10):2499-506.
• Xiaonan Liu, Yingnan Zhao, Li-Ren Cheng. The Role of Pharmacoeconomic Evaluation in Pricing and Reimbursing Medicines and Its Implication to Pharmaceutical Policy in China. Chinese Hospital Management. 2007; 7(26).
• Dandan Zhang, Chunhong Shao, Minhua Shao, Pengrong Yan, Yi Wang, Yixiao Liu, Wenhong Liu, Tong Lin, Yuying Xie, Yingnan Zhao, Daru Lu, Yifeng Li, and Li Jin. Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Biol Psychiatry. 2007 Jun 1;61(11):1244-51.
• Ying Bian, Yingnan Zhao. Regulation Mechanism Analysis of Nurse Professionist in Taiwan. Chinese Hospital Management. 2006; 12(26).
• Feng Zhang, Zheng Li, Bo Wen, Jianhang Jiang, Yungang He, Hui Li, Yingnan Zhao, Xiufeng Song, Ji Qian, Daru Lu, and Li Jin. A frequent partial AZFc deletion does not render an increased risk of spermatogenic impairment in East Asians. Ann Hum Genet. 2006 May; 70(Pt 3):304-13.
• Yifeng Li, Dandan Zhang, Wei Jin, Chunhong Shao, Pengrong Yan, Congjian Xu, Haihui Sheng, Yan Liu, Jinde Yu, Yuying Xie, Yingnan Zhao, Daru Lu, Daniel W. Nebert, Donald C. Harrison, Wei Huang, and Li Jin. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J Clin Invest. 2006 February 1; 116(2): 506–511.